14 results
Chart of Inhalers for Asthma and COPD
 - SABA - Short Acting Beta-2 Agonists
 - SAMA
Combination - LABA ... + LABA Combination ... - ICS + LAMA + ... - ICS - Inhaled ... + LABA Combination
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
/LABA or Med/High ... dose ICS/LABA ... dose ICS/LABA + ... then add on a LABA ... + LABA, tiotropium
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
LAMA: long-acting ... muscarinic antagonist; LABA ... long-acting β2-agonist; ICS ... COPD #GOLD2017 #LAMA ... #LABA #ICS #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
of expiration; ICS ... corticosteroid; LABA ... Management #Pulmonary #LABA ... #LAMA #SABA #SAMA ... #ICS #Pharmacology
COPD Preferred Treatments - GOLD 2018 

COPD is a common progressive respiratory condition that can be
inhalers that include LABA ... beta2 agonist) LAMA ... anticholinergics) and ICS ... /LABA, and lastly ... LAMA/LABA/ICS.
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
ICS: inhaled corticosteroids ... ; SABA: short-acting ... receptor antagonists; LABA
Spinal Cord Injury by Nerve Root Levels
Spinal Root	Sensory	Motor	Reflex
C4	Acromioclavicular Joint	Respiration	None
C5	Radial Antecubital Fossa	Elbow Flexion	Biceps Reflex
C6	Dorsal Thumb	Wrist Extension	Brachioradialis Reflex
C7	Dorsal
Thigh Hip Flexion Cremasteric ... Sphincter None #SpinalCord
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... Beta2 Agonists (LABA ... Here are the LABA ... /ICS combination ... These combo LABA
Incomplete spinal cord syndromes (ISCS)
 • Central - Small Lesion - Suspended sensory deficit, classic cape
cord syndromes (ISCS ... rg.2018170178 #ISCS ... #Incomplete #spinalcord
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Triple Therapy (LAMA ... /LABA/ICS) - ... Bronchodilators (LAMA ... /LABA) & Eosinophils ... low, adding an ICS